POSTER SESSION III
Tuesday, March 10, 2009 — 9:30 AM - 12:00 Noon
Hynes CC Exhibit Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
109
Persistent Tumor-Specific Expression of CD52 but Not CD20 Following Alemtuzumab and Rituximab Treatment in Chronic Lymphocytic Leukemia: Implications for Resistance to Antibody-Based Therapies
(1319)
D Wu, JL Kutok, SJ Rodig - Brigham & Women's Hospital, Boston, MA
CD52 Expression in T Cell Lymphomas
(1197)
Z Ghorab, JW Wong, R Buckstein, M Cheung, S Nofech-Mozes - Sunnybrook Health Sciences Centre, Toronto, Canada
p53 Immunohistochemistry Predicts 17p13(TP53) Deletion in CLL
(1223)
A Jiang, C Qi, H Chang - University Health Network and University of Toronto, Toronto, Canada
"Pseudfollicles", Survival Niches for B-CLL Cells Due to NF-K B Activation Pathway
(1283)
SM Rodriguez-Pinilla, B Herreros, I Castillo, P Algara, S Montes-Moreno, R Diaz de Otazu, M Perez Guillermo, MJ Mestre, C Bellas, MA Piris - CNIO, Madrid, Spain
Morphologic Features in Small Lymphocytic Lymphoma Are Predominantly Not Predictive of Underlying Prognostic FISH or Immunophenotypic Markers
(1196)
C Garcia, K Hunt, H Kang, J Gale, MA Vasef, K Reichard - U. of Pittsburgh, Pittsburgh, PA; U. of New Mexico, Albuquerque, NM; Tricore Reference Lab, Albuquerque, NM
Structural Alterations of the 14q32/IGH Locus in CLL Revealed by Fluorescence In Situ Hybridization and Array-Based Comparative Genomic Hybridization
(1289)
RL Sargent, LV Abruzzo, MJ Keating, WG Wierda, LJ Medeiros, R Luthra, D Jones - UT-MD Anderson Cancer Center, Houston, TX
The t(14;19)(q32;q13)-Positive B-Cell Leukemia: A Comprehensive Genetic and Clinicopathologic Study of Six Cases
(1217)
YO Huh, RP Ketterling, F Vega, JE Kim, LJ Medeiros, LV Abruzzo - University of Texas M. D. Anderson Cancer Center, Houston; Mayo Clinic, Rochester
Bcl-6 Coexpression in Mantle Cell Lymphoma: A Rare Finding Associated with a Lack of CD5 and/or CD3 Coexpression
¤1296¥
AJ Shaw, AM Gown, HC Hwang, PL Kandalaft, LC Goldstein, SJ Kussick - PhenoPath Laboratories, Seattle, WA; IMPRIS, Seattle, WA
Nuclear Staining of SOX11 Is a Reliable Immunohistochemical Marker for Mantle Cell Lymphoma
(1194)
J Gao, L Peterson, Y Chen - Northwestern University Feinberg School of Medicine, Chicago, IL
Characterization of D-Cyclin Proteins in Hematolymphoid Neoplasms
(1257)
RA Metcalf, S Zhao, R Levy, IS Lossos, Y Natkunam - Stanford University, Stanford, CA; University of Miami, Miami, FL
Inhibition of HDM4 Induces p21 Expression in Mantle Cell Lymphoma
(1245)
M Liang, X Han, M Fernandez, M Nguyen, GZ Rassidakis, I Drakos, LJ Medeiros, CE Bueso-Ramos - University of Texas, M.D. Anderson Cancer Center, Houston, TX
Mitotic Index and Cell Cycle Regulatory Proteins as Predictors of Behavior in Typical, Non-Blastoid Mantle Cell Lymphoma
(1261)
A Mogal, A Cashen, J Frater, A Hassan, F Kreisel - Washington University, St. Louis, MO
Immunoexpression of Cell Cycle Molecules Participated in P27Kip1 Degradation in B-Cell Lymphomas
(1297)
C Sirinian, A Symeonidis, N Giannakoulas, H Vlotinou, M Melachrinou - Medical School, University of Patras, Patras, Greece
Chromosomal Aberrations in Thymoma: Review of the Literature and Report of Five Additional Cases
(1241)
AR Laury, V Nose, P Dal Cin - Brigham & Women's Hospital, Boston, MA
Evaluation of 6q Deletion in Waldenstrom's Macroglobulinemia, a Multicenter Collaborative Study
(1172)
H Chang, C Qi, Y Trieu, A Jiang, W Xu, D Reece, C Chen, KH Young, A Chesney, P Jani, C Wang, R Padmore - University Health Network, Toronto, Canada; University of Wisconsin, Wisconsin; Sunnybrook Health Sciences Center, Toronto, Canada; Thunder Bay Health Sciences Center, Thunder Bay, Canada; Mount Sinai Hospital, Toronto, Canada; Ottawa General Hospital, Ottawa, Canada
Significant CD5 Expression on Normal Stage III Hematogones and Mature B-Lymphocytes in Bone Marrow
(1193)
FS Fuda, NJ Karandikar, W Chen - UT Southwestern Medical Center, Dallas, TX
Decreased Surface Immunoglobulin Light Chain Expression by Mature B-Lymphocytes in Serous Fluids: An Assessment of Frequency and Clinical Significance
(1250)
MS Madsen, JH Lunde, R Bryant, MR Lewis - Univ. of Vermont, Burlington, VT
Lymphoma in Northern Iraq, a World Health Organization Classification of 111 Cases
(1322)
RT Yaqo, FK Sulayvani, N AlAllawi, M Hughson - Dohuk University Medical College, Dohuk, Iraq; Hewa Hematology and Oncology Hospital, Sulaimaniyah, Iraq
Comparison of Non-Hodgkin Lymphoma Subtypes in Guatemala and North America/Western Europe
(1263)
A Morovic, H Molina-Kirsch, J Diebold, K Maclennan, K Muller-Hermelink, B Nathwani, J Armitage, D Weisenburger, for the International Non-Hodgkin Lymphoma Classification Project - University of Nebraska Medical Center, Omaha, NE
Insulin-Like Growth Factor-II mRNA-Binding Protein Expression in Leukemias and Lymphomas
(1243)
MP LeGolvan, S Hao, BA Woda - UMassMemorial Healthcare, Worcester, MA
Gene Expression Profile of Nodal Marginal Zone Lymphoma. The Search for Diagnostic Markers
(1157)
JA Arribas, Y Campos-Martin, M Sanchez-Beato, G Roncador, P Algara, G Kanellis, S Montes-Moreno, MA Piris, M Mollejo - Hospital Virgen de la Salud, SESCAM, Toledo, Spain; CNIO, Madrid, Spain
MNDA, a New Marker Useful in the Recognition of Nodal Marginal Zone Lymphoma and Its Differential with Follicular Lymphoma
(1226)
G Kanellis, G Roncador, S Montes-Moreno, JA Arribas, M Mollejo, Y Campos-Martin, M Piris - CNIO, Madrid, Spain
Gene Expression Profiling of Post-Follicular B-Cell Lymphomas Identifies New Biological Insights with Potential Diagnostic and Therapeutic Applications
PJ Kurtin, WJ Chng, G Huang, D Sun, A Dogan - Mayo Clinic, Rochester, MN; National University Hospital, Singapore
135
Post-Follicular B-Cell Lymphomas: A High Resolution Array-Based Analysis Identifies Disease-Specific Patterns of Chromosome Abnormalities
PJ Kurtin, E Braggio, WJ Chng, G Huang, M Barrett, D Sun, R Fonseca, A Feldman, A Dogan - Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AZ; National University Hospital, Singapore; - Translational Genomics, Phoenix, AZ
136
Molecular Prognostic Factors in Splenic Marginal Zone Lymphoma: Correlation of Clinical Behavior with Immunoglobulin Heavy Chain Somatic Mutation Status, Array Comparative Genomic Hybridization and Gene Expression Profiling
(1163)
DS Bosler, ED Remstein, E Braggio, WJ Chng, G Huang, SP Menon, RF McClure, R Fonseca, DX Sun, MJ Maurer, A Dogan - Mayo Clinic, Rochester, MN; National University Hospital, Singapore, Singapore
Differential Staining of Phospho-AKT in Normal Marginal Zone Cells Versus Marginal Zone B Cell Lymphoma
(1227)
S Kemp, KA Rizzo - Indiana University, Indianapolis, IN
Immunoglobulin VH Gene Analysis of Splenic Marginal Zone Lymphoma Histologic Variants
(1159)
DW Bahler, P Szankasi, SD Dufresne, RE Felgar, SH Swerdlow - University of Utah, Salt Lake City, UT; University of Pittsburgh, Pittsburgh, PA
Clonal X Chromosome Inactivation Suggests That Splenic Cord Capillary Hemangioma and Myoid Angioendothelioma Are True Neoplasms and Not Subtypes of Splenic Hamartoma
(1180)
A Chiu, M Czader, L Cheng, M Wang, DM Knowles, H Al-Ahmadie, A Orazi - Weill Cornell Medical College, New York, NY; Indiana University, Indianapolis, IN; The University of Chicago, Chicago, IL
A Characterization of Angiogenesis and VEGF Expression in Gastric MALT Lymphoma, Chronic Gastritis, and Normal Stomach
(1305)
G Turner, MJ Morgan, RK Orr, M Eldibany - Evanston Northwestern Healthcare, Evanston, IL
The Nuclear Factor-Kappa B Pathway: A Role in Primary Cutaneous Marginal Zone B-Cell Lymphomas?
(1270)
MC Patel, S Bhagavathi, S Warren, M Amin, RK Malhotra, AM Blenc - William Beaumont Hospital, Royal Oak, MI; Indiana University, Indianapolis, IN
Basal Activation of NFkB Protein Signaling Pathway in Follicular Lymphoma In Vivo
(1239)
AE Kovach, MK Humsi, ES Jaffe, KR Calvo - National Cancer Institute, NIH, Bethesda, MD
Follicular Lymphoma Involving the Small Intestine: Is There an Association with Gastric Disease or Helicobacter Pylori?
(1260)
RN Miranda, T Muzzafar, LJ Medeiros - M.D. Anderson Cancer Center, Houston, TX
Biological Characterization of Stage I Follicular Lymphoma According to Extranodal or Nodal Primary Origin and t(14;18) Status Using High-Resolution Array-Based Comparative Genomic Hybridization
(1316)
OK Weinberg, L Ma, K Seo, R Hoppe, DA Arber - Stanford University, Stanford, CA
MUM1/IRF4 Is Expressed in a Subset of Follicular Lymphoma with BCL6 Translocation and Short Survival
(1284)
HJ Rogers, J Bodo, T Jin, TE O'Brien, ED Hsi - Cleveland Clinic, Cleveland, OH; MetroHealth Medical Center, Cleveland, OH
Three-Dimensional Image Analysis of Benign vs Malignant Follicular Lymphoid Proliferations
(1299)
AR Sohani, V Brodsky, AM Ackerman, EP Hochberg, JR Gilbertson, Y Yagi - Massachusetts General Hospital, Boston; Mass General Hospital Cancer Center, Boston, MA
PRAME Expression in Follicular Lymphoma and Diffuse Large B Cell Lymphoma
(1272)
M Perez, JA Shafer, C Curry, Y Zu, A Ewton, G Dotti, C Chang - The Methodist Hospital, Houston, TX; Baylor College of Medicine, Houston, TX
CD81 Protein Is Expressed in Normal Germinal Center B-Cells and in Subtypes of Human Non-Hodgkin Lymphomas
(1249)
RF Luo, S Zhao, R Tibshirani, IS Lossos, R Advani, D Gratzinger, A Wong, N Talrega, R Levy, S Levy, Y Natkunam - Stanford University, Stanford, CA; University of Miami, Miami, FL
button next to any title to add to Itinerary Planner...
Add
